NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/20/2024
Back to search
Official data from USPTO
THE SUSTAINABLE HEALTHCARE CO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE SUSTAINABLE HEALTHCARE CO
ST13
US500000090863643Class
5, 35
Filing
90863643
Registration
7311964
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
02/20/2024
Trademark type
Word
Nice classes
5, 35
Filing date
08/03/2021
Registration date
02/20/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/20/2024
Last transaction
02/20/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
11/18/2022
First use in commerce
11/18/2022
Drawing code
4
Owner type
03
Owner location
Washington, D. C., DC, US
Examiner
MCBRIDE, CAMERON L
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Patel & Gong, Inc.
Representatives
Francis G. Gleason Jr. GLEASON & GLEASON P. C.
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorderssports related injuriesfor knee cartilage regeneration; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparationsanticoagulants; Pharmaceutical preparationsantidepressants; Pharmaceutical preparationsantivirals; Pharmaceutical preparationsappetite suppressants; Pharmaceutical preparationsinjectable contraceptives; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists; Pharmaceutical preparationsan analgesic for human consumption taken orally; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs
Class 35
Retail pharmacy services; Retail store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies
Publications
History of USPTO decisions and trademark events.
37 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
02/20/2024
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
01/17/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/16/2024
IUAA
USE AMENDMENT ACCEPTED
01/16/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
12/26/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/26/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/26/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/26/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/28/2023
GNRT
NON-FINAL ACTION E-MAILED
08/28/2023
CNRT
NON-FINAL ACTION WRITTEN
08/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/09/2023
IUAF
USE AMENDMENT FILED
08/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
08/08/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/08/2023
GNRT
NON-FINAL ACTION E-MAILED
05/08/2023
CNRT
NON-FINAL ACTION WRITTEN
05/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/20/2023
ALIE
ASSIGNED TO LIE
04/20/2023
NREV
NOTICE OF REVIVAL - E-MAILED
01/24/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/23/2023
PETG
PETITION TO REVIVE-GRANTED
01/23/2023
PROA
TEAS PETITION TO REVIVE RECEIVED
01/23/2023
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
11/21/2022
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
11/21/2022
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
11/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/06/2022
GNRT
NON-FINAL ACTION E-MAILED
05/06/2022
CNRT
NON-FINAL ACTION WRITTEN
05/06/2022
DOCK
ASSIGNED TO EXAMINER
04/29/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/08/2021
NWAP
NEW APPLICATION ENTERED
08/06/2021
Continuous trademark protection
Get notified about every new filing that threatens THE SUSTAINABLE HEALTHCARE CO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.